Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Fibrosis; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | Phase 2 | ClinicalTrials |
| Asthma | Phase 1 | ClinicalTrials |
| Eosinophilic Esophagitis; Esophagitis | Phase 2 | ClinicalTrials |
| Asthma | Phase 1/Phase 2 | ClinicalTrials |
| Fibrosis; Neoplasm Metastasis; Pulmonary Fibrosis; Scleroderma, Diffuse; Scleroderma, Systemic; Sclerosis | Phase 2 | ClinicalTrials |
| Asthma | Phase 1/Phase 2 | ClinicalTrials |
| Asthma | Phase 2 | ClinicalTrials |
| Crohn Disease | Phase 2 | ClinicalTrials |
| Keloid; Recurrence | Phase 2 | ClinicalTrials |
| Rhinitis; Rhinitis, Allergic | Phase 2 | ClinicalTrials |
| Fibrosis; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | Phase 2 | ClinicalTrials |
CONTENTS